Eutropics Pharmaceuticals Inc
- View government funding actions
- Cambridge, MA 02138
- Phone: 617-803-1511
- Corporate URL: www.eutropics.com
- Estimated Number of Employees: 8
- Estimated Annual Receipts: $1
- Business Start Date: 2005
- Contact Person: Michael Cardone
- Contact Phone: 617-803-1511
- Contact Email: mcardone@eutropics.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- For Profit Organization
- Industries Served: Machine Shops, Computer Terminal and Other Computer Peripheral Equipment Manufacturing, Radio and Television Broadcasting and Wireless Communications Equipment Manufacturing, Audio and Video Equipment Manufacturing, Other Electronic Component Manufacturing, Other Clothing Stores, All Other Miscellaneous Store Retailers (except Tobacco Stores), All Other Professional, Scientific, and Technical Services, Other Automotive Mechanical and Electrical Repair and Maintenance, Police Protection
- Product Areas: INSTALL OF VEHICULAR EQ, INSTALLATION OF EQUIPMENT- VEHICULAR EQUIPMENT COMPONENTS, INSTALL OF SERVICE & TRADE EQ, INSTALLATION OF EQUIPMENT- SERVICE AND TRADE EQUIPMENT, INSTALLATION OF EQUIPMENT- FIRE FIGHTING/RESCUE/SAFETY EQUIPMENT; ENVIRON PROTECT EQUIPMENT/MATLS, INSTALL OF FIRE-RESCUE-SAFETY EQ, INSTALLATION OF EQUIPMENT- COMMUNICATION, DETECTION, AND COHERENT RADIATION EQUIPMENT, INSTALL OF COMMUNICATION EQ, INSTALL OF ELECT-ELCT EQ, INSTALLATION OF EQUIPMENT- ELECTRICAL AND ELECTRONIC EQUIPMENT COMPONENTS, INSTALLATION OF EQUIPMENT- ALARM, SIGNAL, AND SECURITY DETECTION SYSTEMS, INSTALL OF ALARM & SIGNAL SYSTEM, INSTALL OF MISC EQ, INSTALLATION OF EQUIPMENT- MISCELLANEOUS
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $199,892 - Monday the 22nd of June 2015
National Institutes Of Health
NIH, NCI, OD OM OA OFC ACQUISITIONS
IGF::OT::IGF OTHER FUNCTIONS R&D- BIOMEDICAL (BASIC RESEARCH) - $1,499,746 - Friday the 1st of March 2013
National Institutes Of Health
NIH, NCI, OD OM OA OFC ACQUISITIONS
IGF::OT::IGF OTHER FUNCTIONS TOPIC 277, DEVELOPING BH3 PROFILING AS A COMPANION DIAGNOSTIC FOR VELCADE TREATMENT FOR MULTIPLE MYELOMA
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.